from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1618/tesB1

LFCtreatmentdescriptionclass of inhibitor

-0.546

Amikacinug/mL Amikacintranslation

-1.744

Cap5-10ug/mL Capreomycintranslation

-1.644

Rox10-50 ug/mL Roxithromycintranslation

-0.114

SM2-5 ug/mL Streptomycintranslation

-1.583

Tet5-10 ug/mL Tetracyclinetranslation

0.568

Rif0.2-5ug/mL Rifampicintranscription

-0.117

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.467

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.256

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.300

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.580

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.258

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.774

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.637

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.777

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.009

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.129

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.027

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.255

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.468

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.654

KCN5-20 ug/mL Potassium cyaniderespiration

-0.431

NaN30.2-2 mM Sodium aziderespiration

-0.332

Nigericin50 uM Nigericinrespiration

0.052

TRC10-150 ug/mL Triclosanrespiration

-0.835

TRZ10-25 ug/mL Thioridazinerespiration

-1.546

Valinomycin0.5-10 uM Valinomycinrespiration

-0.695

ZnSO42 mM ZnSO4respiration

-0.181

menadione6-10 ug/mL Menadionerespiration

0.083

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.045

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.070

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.464

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.099

NRP_1Non-replicating persistence stage 1dosRassociated

0.053

Amp0.2mg/mL AmpicillincellWall

0.211

Cephalexin20-100 ug/mL CephalexincellWall

-0.223

Cerulenin0.32-5 ug/mL CerulenincellWall

0.287

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.125

EMB10-20 ug/mL EthambutolcellWall

-0.663

Eta12-40 ug/mL EthionamidecellWall

-0.804

INH0.2-0.4 ug/mL IsoniazidcellWall

0.060

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.317

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.509

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.053

BZA0.12 mg/mL BenzamidearomaticAmides

1.106

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.675

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.160

H2O24 mM hydrogen peroxideDNAdamaging

-0.536

Levo10 ug/mL LevofloxacinDNAdamaging

0.906

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.825

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.237

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.458

UVUV-irradiationDNAdamaging

-0.374

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.071

Antimycin12.5-50 ug/mL Antimycin A?

-0.374

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.207

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.408

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.934

PA8240.2-2 ug/mL PA-824?

-0.368

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.125

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.526

Verapamil50 uM Verapamil?

-0.815

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.546

methoxatin10-20 ug/mL Methoxatin?